Treatment of Metabolic (Dysfunction)-Associated Fatty Liver Disease: Evidence from Randomized Controlled Trials

登录注册会员服务联系我们

Treatment of Metabolic (Dysfunction)-Associated Fatty Liver Disease: Evidence from Randomized Controlled Trials—A Short Review

Published:2024-08-01 Issue: Volume: Page:
ISSN:1540-4196
Container-title:Metabolic Syndrome and Related Disorders
language:en
Short-container-title:Metabolic Syndrome and Related Disorders

Author:

Kitsios Konstantinos¹^ORCID,Trakatelli Christina-Maria¹,Antza Christina¹,Triantafyllou Areti¹,Sarigianni Maria¹,Kotsis Vasilios¹

Affiliation:

1. Third Department of Internal Medicine, Aristotle University of Thessaloniki, Papageorgiou General Hospital, Thessaloniki, Greece.

Publisher

Mary Ann Liebert Inc

Link

https://www.liebertpub.com/doi/pdf/10.1089/met.2024.0059

Reference44 articles.

1. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases

2. Nonalcoholic Fatty Liver Disease 2020: The State of the Disease

3. A Structured Literature Review of the Epidemiology and Disease Burden of Non-Alcoholic Steatohepatitis (NASH)

4. Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis

5. Treatment of patients with type 2 diabetes and non-alcoholic fatty liver disease: current approaches and future directions

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP